Antonia Müller

ORCID: 0000-0003-4420-9466 · 5 papers in corpus
article 2000
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest®for continuous combined hormone replacement therapy in postmenopausal women
·doi:10.3109/13697130009167612

Objective To compare the efficacy and endometrial safety of two estradiol valerate/dienogest combinations with Kliogest® in the treatment of postmenopausal symptoms.Design This was a double-blind, randomized, multicenter study.Methods Patie…

article 2000
Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest — a dose-ranging study
·doi:10.1016/s0378-5122(00)00112-2

ObjectivesTo determine the progestational efficacy of continuous treatment with various doses of dienogest, combined with oestradiol valerate, on the basis of endometrial histology, effect on climacteric symptoms and bleeding profile in pos…

article 2000
Safety and efficacy profile of a high dose treatment of endometriosis with 20 mg dienogest per day
·doi:10.1016/s0020-7292(00)82572-2
article 1998
Der Einfluß einer kontinuierlich-kombinierten Hormonersatz-Therapie mit Estradiolvalerat und Dienogest auf das Blutungsverhalten und das Endometrium postmenopausaler Frauen

Ziel: Dienogest (DNG, 17alpha-Cyanomethyl-17beta-hydroxy-4,9- estradien-3-on) repräsentiert einen neuen Typ der 19-Norgestagene. Es zeigt bezüglich der antiandrogenen Partialwirkung Ähnlichkeiten zu den C21-Progesteronderivaten. Deshalb sol…

article 1971
[Extragenital endometriosis. Report of a case of pulmonary endometriosis].
Schweizerische medizinische Wochenschrift